BTIG Research assumed coverage on shares of Sunesis Pharmaceuticals (NASDAQ:SNSS) in a research note issued to investors on Tuesday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $5.50 price target on the stock. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) belongs to Healthcare sector. Its weekly performance is -4.64%. On last trading day company shares ended up $2.57. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) distance from 50-day simple … Continue reading Top Movers: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Kingtone Wirelessinfo Solution Holding Ltd. (NASDAQ:KONE), Adobe Systems Incorporated (NASDAQ:ADBE), Facebook Inc (NASDAQ:FB), UDR, Inc. (NYSE:UDR)